ABRYSVO, Generations of Protection
ABRYSVO represents a promise to protect the most vulnerable before illness takes hold. This RSV vaccine redefines prevention across generations.
As a maternal vaccine, it empowers mothers to pass protection to their infants at life’s most fragile beginning.
For seniors, ABRYSVO strengthens resilience, reducing the burden of RSV where age weakens immunity. One vaccine, two critical moments, and a shared purpose.
This is science in service, where health is passed forward, independence preserved, and communities safeguarded.
Prevention is not passive. It is proactive, compassionate, and enduring.
Comirnaty, Collective Protection
Comirnaty stands as a testament to what science can deliver when urgency meets responsibility. Developed by Pfizer, it protects individuals five years of age and older, reinforcing a shared commitment to health across generations.
This vaccine is not only about preventing severe illness—it is about preserving classrooms, families, and communities. It transforms innovation into action, research into resilience. Each dose represents trust in evidence, care for one another, and belief in progress.
Comirnaty affirms that public health is personal, and protection is strongest when it is shared.
Mevrometostat, Defying Resistance
Mevrometostat represents a new front in the fight against androgen-resistant prostate cancer, where resistance has too often meant limitation.
Developed by Pfizer, it challenges the biology of progression and reframes what targeted therapy can achieve. This is science confronting adaptation with precision, addressing prostate cancer that no longer responds to conventional hormonal control.
Mevrometostat is not incremental hope; it is intentional disruption—designed to slow, interrupt, and redefine the trajectory of advanced prostate cancer.
Mevrometostat stands for persistence when cancer adapts, and progress when patients need it most.
